DRAP approves Chinese diabetes medicine

The insulin glargine injecta BASAGINE developed by a Chinese pharmaceutical company has received approval for registration by the Drug Regulatory Authority of Pakistan (DRAP), China Economic Net (CEN) reported. According to the company, it is the first insulin glargine injection (prefilled injection pen) biosimilar drug in Pakistan, Insulin glargine injection is an essential long-acting insulin […]